Skip to main content

Table 1 Comparison of patient characteristics versus preoperative platelet distribution width (PDW)

From: Prognostic significance of the combination of preoperative red cell distribution width and platelet distribution width in patients with gastric cancer

Variables

PDWHigh (n = 219)

PDWLow (n = 226)

P value

Age (years)

  

0.0014

  <  70 (n = 217)

90 (41.5%)

127 (58.5%)

 

  ≥ 70 (n = 228)

129 (56.6%)

99 (43.4%)

 

Gender

  

0.23

 Male (n = 328)

167 (50.9%)

161 (49.1%)

 

 Femal (n = 117)

52 (44.4%)

65 (55.6%)

 

Tumor size (cm)

  

0.52

  <  4 (n = 281)

135 (48.0%)

146 (52.0%)

 

  ≥ 4 (n = 164)

84 (51.2%)

80 (48.8%)

 

Histology a

  

0.059

 Differentiated (n = 244)

130 (53.3%)

114 (46.7%)

 

 Undifferentiated (n = 201)

89 (44.3%)

112 (55.7%)

 

Depth of invasion b

  

0.96

 T1 (n = 284)

140 (49.3%)

144 (50.7%)

 

 T2/3/4 (n = 161)

79 (49.1%)

82 (50.9%)

 

Lymph node metastasis

  

0.6

 Absent (n = 342)

166 (48.5%)

176 (51.5%)

 

 Present (n = 103)

53 (51.5%)

50 (48.5%)

 

Lymphatic invasion

  

0.5

 Absent (n = 186)

88 (47.3%)

98 (52.7%)

 

 Present (n = 259)

131 (50.6%)

128 (49.4%)

 

Vascular invasion

  

0.88

 Absent (n = 232)

115 (49.6%)

117 (50.4%)

 

 Present (n = 213)

104 (48.8%)

109 (51.2%)

 

Stage of disease

  

0.77

 I (n = 310)

154 (49.7%)

156 (50.3%)

 

 II / III (n = 135)

65 (48.1%)

70 (51.9%)

 

Approach

  

0.77

 Open (n = 257)

129 (50.2%)

128 (49.8%)

 

 Laparoscopy (n = 188)

90 (47.9%)

98 (52.1%)

 

Gatrectomy (total vs. distal and proximal partial)

 

0.073

 

 Total (n = 95)

39 (41.1%)

56 (58.9%)

 

 Distal or proximal (n = 350)

180 (51.4%)

170 (48.6%)

 

Lymph node dissection

  

0.76

 D0 / D1 (n = 312)

155 (49.7%)

157 (50.3%)

 

 D2 (n = 133)

64 (48.1%)

69 (51.9%)

 

Adjuvant chemotherpy

  

0.36

 Absent (n = 377)

189 (50.1%)

188 (49.9%)

 

 Present (n = 68)

30 (44.1%)

38 (55.9%)

 
  1. aDifferentiated or undifferentiated; Differentiated, papillary or tubular adenocarcinoma; undifferentiated, poorly differentiated or mucinous adenocarcinoma, or signet-ring cell carcinoma
  2. bDepth of invasion: T1, tumor invasion of the lamina propria or submucosa; T2, tumor invasion of the muscularis propria; T3, tumor invasion of the subserosa; T4, tumor penetration of the serosa or tumor invasion of adjacent organs